NOWDiagnostics
And manufactures diagnostic tests that utilize a single drop of blood and deliver results within minutes.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | $22.5m | Series B | |
| Total Funding | 000k | ||
Related Content
NOWDiagnostics, Inc. (NOWDx), founded in 2014 and based in Springdale, Arkansas, develops and manufactures over-the-counter (OTC) and point-of-care (POC) diagnostic tests. Although the company was incorporated in 2014, the proprietary ADEXUSDx™ technology has been under development for over 15 years. Dr. Qinwei Shi was a key figure in revolutionizing the lateral flow assay testing that the company's products are based on.
The company's core business revolves around its ADEXUSDx™ product line, which uses a single drop of blood to deliver results for a variety of conditions within minutes. This technology is designed to be self-contained and easy to use, making it suitable for both professional healthcare settings (point-of-care) and for consumers to use at home (over-the-counter). The business model focuses on the manufacturing and sale of these diagnostic tests.
NOWDiagnostics aims to empower individuals to conduct their own health testing conveniently and receive rapid results. Their product suite includes tests for a range of common conditions, illnesses, and diseases, positioning the company as a key player in the shift towards decentralized diagnostics.
Keywords: diagnostic testing, point-of-care, over-the-counter tests, lateral flow assay, blood test, medical diagnostics, healthcare technology, self-testing, ADEXUSDx, rapid diagnostics